Structural and mechanistic studies of the orf12 gene product from the clavulanic acid biosynthesis pathway. (30th July 2013)

• Record Type: Journal Article
• Authors: Valegård, Karin; Iqbal, Aman; Kershaw, Nadia J.; Ivison, David; Généreux, Catherine; Dubus, Alain; Blikstad, Cecilia; Demetriades, Marina; Hopkinson, Richard J.; Lloyd, Adrian J.; Roper, David I.; Schofield, Christopher J.; Andersson, Inger; McDonough, Michael A.
• Is Part Of: Acta crystallographica. Volume 69:Part 8(2013:Aug.)
• Page Start: 1567
• Page End: 1579
• Publication Date: 2013-07-30
• Subjects: Biomolecules -- Structure -- Periodicals; Physical biochemistry -- Periodicals; X-ray crystallography -- Periodicals; Crystallography -- Periodicals; 572
• DOI: 10.1107/S0907444913011013
• Languages: English
• ISSNs: 0907-4449

Abstract

<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Structural and biochemical studies of the <italic>orf12</italic> gene product (ORF12) from the clavulanic acid (CA) biosynthesis gene cluster are described. Sequence and crystallographic analyses reveal two domains: a C‐terminal penicillin‐binding protein (PBP)/β‐lactamase‐type fold with highest structural similarity to the class A β‐lactamases fused to an N‐terminal domain with a fold similar to steroid isomerases and polyketide cyclases. The C‐terminal domain of ORF12 did not show β‐lactamase or PBP activity for the substrates tested, but did show low‐level esterase activity towards 3′‐<italic>O</italic>‐acetyl cephalosporins and a thioester substrate. Mutagenesis studies imply that Ser173, which is present in a conserved S<italic>XX</italic>K motif, acts as a nucleophile in catalysis, consistent with studies of related esterases, β‐lactamases and D‐Ala carboxypeptidases. Structures of wild‐type ORF12 and of catalytic residue variants were obtained in complex with and in the absence of clavulanic acid. The role of ORF12 in clavulanic acid biosynthesis is unknown, but it may be involved in the epimerization of (3<italic>S</italic>, 5<italic>S</italic>)‐clavaminic acid to (3<italic>R</italic>, 5<italic>R</italic>)‐clavulanic acid.</p> </abstract>